BioHealth News
Deka Biosciences Publishes New Data in Cell Reports Medicine, Announces Search for Combination Partners for DK210(EGFR)
Germantown, MD — Deka Biosciences, a clinical-stage biotechnology company developing next-generation cytokine therapies for cancer and inflammatory disease, announced the publication of a peer-reviewed…
Read More
MaxCyte Announces Strategic Platform Licensing Agreement with Anocca AB to Advance TCR-T Cell Therapy Pipeline
MaxCyte’s Flow Electroporation® Technology will support non-viral gene editing in the manufacture of Anocca’s TCR-T cell therapies ROCKVILLE, Md., July 31, 2025 (GLOBE NEWSWIRE)…
Read More
Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics
Acquisition strengthens Supernus’ leading presence in neuropsychiatric conditions with an innovative commercial product, ZURZUVAE® (zuranolone), and a novel CNS discovery platform, accelerating mid- to…
Read More
BioHub Maryland, Powered by the Maryland Tech Council, Welcomes Cutting-Edge Contributions from Biopharma Industry Leaders
ROCKVILLE, Md.--(BUSINESS WIRE)--BioHub Maryland, powered by the Maryland Tech Council, is pleased to announce that over a dozen biopharmaceutical industry leaders have gifted critical…
Read More
At Johns Hopkins, University Research Powers Biotech—But Federal Cuts Loom
Catherine Graham / Johns Hopkins University biomedical engineer Jean Fan and her team develop—and freely share—computational tools that give researchers everywhere the ability to discover breakthrough…
Read More
Emerging biotechs get bearish to weather market trends, finds BIO report
“Small companies are the lifeblood of the industry and a lot of what they do, and what they’re experiencing, greatly affects the industry as…
Read More
WBJ: Space problem – Montgomery County already has a glut of lab space. HHS cuts could make it worse
By Sara Gilgore – Staff Reporter, Washington Business Journal - Jul 25, 2025 -Montgomery County is already contending with a record glut of lab…
Read More
WBJ: Johnson & Johnson’s D.C. incubator to leave Children’s National Hospital’s Walter Reed campus
By Sara Gilgore – Staff Reporter, Washington Business Journal - Johnson & Johnson Innovation’s D.C. incubator is preparing to leave Children’s National Hospital’s Research and Innovation…
Read More
AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D
AstraZeneca today announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This…
Read More
Phlow Announces Close of $37M Series C Financing to Accelerate Modern Medicine Development and Manufacturing in America
Richmond, VA, July 22, 2025 (GLOBE NEWSWIRE) -- Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced the successful…
Read More
TEDCO Invests in Zero Point Five Therapeutics
COLUMBIA, Md., (July 21, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced a recent Venture Funds investment for nearly $350,00 in Zero Point Five…
Read More
BioPharmaDive: Biotech startup funding dried up in second quarter, HSBC finds
7/17/2025 - Gwendolyn Wu - Even before HSBC’s report, there were signs of a biotech funding slowdown. Research the investment bank Jefferies published in May and…
Read More
3 Days, 1 Region, Endless Opportunity: What to Expect at BHCR Week 2025
Planning is well underway for BioHealth Capital Region Week 2025, and hundreds of attendees have already registered for the Forum taking place September 23–25…
Read More
I-Mab Strengthens Givastomig Intellectual Property Portfolio through Acquisition of Bridge Health
ROCKVILLE, Md., July 17, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision…
Read More
60 Degrees Pharmaceuticals Announces Pricing of Up to $10 Million Public Offering
WASHINGTON, July 15, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (the “Company” or “60 Degrees”) (Nasdaq: SXTP; SXTPW), a pharmaceutical company focused on…
Read More